CONTRACT REDLINE & NEGOTIATION
Finalizing the clinical trial agreement is one of the most consistent bottlenecks in study start-up. Sites that sign without a thorough review pay for it twice: once in time, once in exposure.
Most sites accept the sponsor's first offer. That mistake compounds over every study you run.
CTA-specific expertise catches what generic review misses.
WHAT WE DO
Generic review misses what matters in a CTA
We review, redline, and negotiate clinical trial agreements on behalf of your site — without unnecessary back-and-forth or prolonged cycles that delay activation.
We also build and maintain contract playbooks that compress negotiation time on every study that follows.
WHAT YOU GET
What changes when Elevate handles your budget
Hidden costs identified and recovered before the study starts.
A clear picture of financial feasibility before you commit.
Faster start-up timelines, across every study
HOW IT WORKS
THE PROCESS
1
Build Your Playbook
Your requirements and preferred positions, captured up front.
2
Submit the CTA
Your team sends the agreement to Elevate for review.
3
We redline and negotiate
Directly with the CRO or sponsor
4
Final Review
We facilitate the signature process.
Protect Your Site Before You Sign
Connect with our team and see what CTA-specific review catches.